Re-expression of ABI3-binding protein suppresses thyroid tumor growth by promoting senescence and inhibiting invasion
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Loss of ABI gene family member 3-binding protein (ABI3BP) expression may be functionally involved in the pathogenesis of cancer. Previous reports have indicated a loss of expression in lung cancer and a presumed role in inducing cellular senescence. We show here that ABI3BP expression is significantly decreased in most malignant thyroid tumors of all types. To better understand ABI3BP's role, we created a model by re-expressing ABI3BP in two thyroid cancer cell lines. Re-expression of ABI3BP in thyroid cells resulted in a decrease in transforming activity, cell growth, cell viability, migration, invasion, and tumor growth in nude mice. ABI3BP re-expression appears to trigger cellular senescence through the p21 pathway. Additionally, ABI3BP induced formation of heterochromatin 1-binding protein gamma-positive senescence-associated (SA) heterochromatin foci and accumulation of SA beta-galactosidase. The combination of a decrease in cell growth, invasion, and other effects upon ABI3BP re-expression in vitro helps to explain the large reduction in tumor growth that we observed in nude mice. Together, our data provide evidence that the loss of ABI3BP expression could play a functional role in thyroid tumorigenesis. Activation of ABI3BP or its pathway may represent a possible basis for targeted therapy of certain cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278 · cited 1×
“It was demonstrated that HP1g mediates SAHF formation and E2F gene silencing occurs during senescence (Narita et al. 2003).”
BackgroundBRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993 · cited 2×
“Several groups detected the occurrence of senescence in pre-malignant tumor whereas cells in malignant tumors are unable to trigger senescence (Chen et al .”
BackgroundSenescence in premalignant tumours
Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., Benguría, A., Zaballos, A., Flores, J. M., Barbacid, M., et al. (2005) · Nature · doi:10.1038/436642a · Cited by 1,482 · cited 2×
“2003, Collado et al .”
Senescence of human fibroblasts induced by oncogenic Raf
Zhu, J., Woods, D., McMahon, M., & Bishop, J. M. (1998) · Genes & Development · doi:10.1101/gad.12.19.2997 · Cited by 826 · cited 1×
“Regarding the RAS/RAF/MAPK/ERK pathways, it has been suggested that RAF-induced senescence appears to have no obvious requirement for either p53 or p21 (Zhu et al .”
BackgroundThe power and the promise of oncogene-induced senescence markers
Collado, M., & Serrano, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1884 · Cited by 404 · cited 3×
“1995, Collado & Serrano 2006).”
BackgroundInfluentialIs β-Galactosidase Staining a Marker of Senescence in Vitro and in Vivo?
Severino, J., Allen, R. G., Balin, S., Balin, A., & Cristofalo, V. J. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4875 · Cited by 370
Regulation of cellular senescence by p53
Itahana, K., Dimri, G., & Campisi, J. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02228.x · Cited by 365
Oncogene-Induced Senescence: Putting the Brakes on Tumor Development
Braig, M., & Schmitt, C. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4006 · Cited by 274 · cited 1×
“…markers for the senescent state are still missing, some characteristics such as SA b -galactosidase (SA-b -gal) activity, Ki67 downregulation, expression of cell cycle inhibitors such as p21 and chromatin remodeling have proven useful as indicators of cellular senescence (Braig & Schmitt 2006).”
BackgroundMolecular signature of oncogenic ras-induced senescence
Mason, D. X., Jackson, T. J., & Lin, A. W. (2004) · Oncogene · doi:10.1038/sj.onc.1208172 · Cited by 127
NESH (Abi‐3) is present in the Abi/WAVE complex but does not promote c‐Abl‐mediated phosphorylation
Hirao, N., Sato, S., Gotoh, T., Maruoka, M., Suzuki, J., Matsuda, S., Shishido, T., & Tani, K. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.10.065 · Cited by 25 · cited 1×
“2002 b , Hirao et al .”
Cited by
A genome-wide association study of suicide attempts and suicidal ideation in U.S. military veterans
Kimbrel, N. A., Garrett, M. E., Dennis, M. F., Hauser, M. A., Ashley-Koch, A. E., & Beckham, J. C. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.07.017 · Cited by 52
ABI3 ectopic expression reduces in vitro and in vivocell growth properties while inducing senescence
Latini, F. R., Hemerly, J. P., Freitas, B. C., Oler, G., Riggins, G. J., & Cerutti, J. M. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-11 · Cited by 48
Self-citationWillis-Owen, S. A. G., Thompson, A., Kemp, P. R., Polkey, M. I., Cookson, W. O. C. M., Moffatt, M. F., & Natanek, S. A. (2018) · Scientific Reports · doi:10.1038/s41598-018-29789-6 · Cited by 42
Arginase 2 and nitric oxide synthase: Pathways associated with the pathogenesis of thyroid tumors
Sousa, M. S. A., Latini, F. R. M., Monteiro, H. P., & Cerutti, J. M. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.06.006 · Cited by 39
“WRO cells were collected to measure protein levels as previously described [19].”
MethodSelf-citationABI3, a component of the WAVE2 complex, is potentially regulated by PI3K/AKT pathway
Moraes, L., Zanchin, N. I. T., & Cerutti, J. M. (2017) · Oncotarget · doi:10.18632/oncotarget.18840 · Cited by 22
“Down-regulation of these pathways, known as crucial to tumor growth and differentiation in different tumors subtypes [23–25], can explain, at least in part, the biological effects observed following forced expression of ABI3 in follicular thyroid carcinoma cells [22].”
Self-citation
Metadata
- Authors
- Latini, F. R. M., Hemerly, J. P., Oler, G., Riggins, G. J., & Cerutti, J. M.
- Venue
- Endocrine Related Cancer
- Publisher
- Bioscientifica
- Published
- 2008-05-22
- Volume
- 15
- Issue
- 3
- Pages
- 787-799
- ISSN
- 1351-0088 (ISSN-L)
- 1479-6821
- OpenAlex
- W2107264101
- Cited by
- 62
- References
- 11
- FWCI
- 2.40
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.